Roberta Rayra Martins Chaves

Prof. Dr. Roberta Rayra Martins Chaves


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Metabolomics
Verified
Journal Article
Closed access
PDF file
JVJéssica Gardone Vitório
Jéssica Gardone Vitório
FDFilipe Fideles Duarte-Andrade
Filipe Fideles Duarte-Andrade
TPThaís Santos Fontes Pereira
Thaís Santos Fontes Pereira
FFFelipe Paiva Fonseca
Felipe Paiva Fonseca
LALarissa Stefhanne Damasceno Amorim
Larissa Stefhanne Damasceno Amorim
RGRicardo Santiago Gomez
Ricardo Santiago Gomez

2 January 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
NGNathalia Sernizon Guimarães
Nathalia Sernizon Guimarães
JJJulliane Joviano-Santos
Julliane Joviano-Santos
MRMarcela Gomes Reis
Marcela Gomes Reis
RCRoberta Rayra Martins Chaves
Roberta Rayra Martins Chaves

1 January 2020 in Brazilian Oral Research
Verified
Journal Article
Open access
RCRoberta Rayra Martins Chaves
Roberta Rayra Martins Chaves
CGCarolina Cavaliéri Gomes
Carolina Cavaliéri Gomes
RGRicardo Santiago Gomez
Ricardo Santiago Gomez
In less than four months, an unprecedented pandemic changed the world scenario, closing institutions and commerce, paralyzing sports championships, blocking frontiers, and putting almost all populations in a house quarantine regimen. Immunocompromised patients are within the high-risk group to severe outcomes from COVID-19. However, there is no clear evidence of the association between impaired immune host status and complications from SARS-CoV-2 infection so far. The virus is transmitted by inhalation or direct contact with infected secretions, and therefore the dental office is a highly susceptible environment for such transmission. Here, we review the literature and discuss immunological COVID-19 related issues. We also make suggestions for immunocompromised patients’ support in this new emerging context of clinical dental practice. Until comprehensive findings are published, individuals with impaired immunity should be considered as high-risk. Cross infection control procedures for the clinical care of immunocompromised patients should follow the same guidelines that are being proposed for immunocompetent ones. However, during the active outbreak, people under immunosuppressive conditions should not receive elective procedures, even if they do not have symptoms or exposure history to COVID-19, and in case of emergence, care must be done in a separate airborne room. In the pos-pandemic phase, the dental care general recommendations should be the same for all subjects. Changes in the current guidelines have been proposed to SARS-CoV-2 infection control in order to provide the best and safe dental practice. However, they still need to be validated by future studies.

23 November 2019 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
RCRoberta Rayra Martins Chaves
Roberta Rayra Martins Chaves
LGLetícia Martins Guimarães
Letícia Martins Guimarães
TPThaís Santos Fontes Pereira
Thaís Santos Fontes Pereira
NPNúbia Braga Pereira
Núbia Braga Pereira
Bruno Ramos ChrcanovicBruno Ramos Chrcanovic
Bruno Ramos Chrcanovic
RGRicardo Santiago Gomez
Ricardo Santiago Gomez

9 January 2020 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
LSLauren Frenzel Schuch
Lauren Frenzel Schuch
JAJosé Alcides Almeida de Arruda
José Alcides Almeida de Arruda
CMCarla Mosconi
Carla Mosconi
LKLaura Borges Kirschnick
Laura Borges Kirschnick
RPRodrigo Finger de Carvalho Pinho
Rodrigo Finger de Carvalho Pinho
RMRicardo Alves de Mesquita
Ricardo Alves de Mesquita

MRMarcela Gomes Reis
Marcela Gomes Reis
LLLucas Carvalho Lopes
Lucas Carvalho Lopes
ASAna Beatriz Amaral M. De A. Sanches
Ana Beatriz Amaral M. De A. Sanches
NGNathalia Sernizon Guimarães
Nathalia Sernizon Guimarães
RCRoberta Rayra Martins Chaves
Roberta Rayra Martins Chaves
Oral squamous cell carcinoma (OSCC) is the sixth most common type of cancer globally. While smoking is a key risk factor, rising cases in non-smokers highlight the need to explore other factors like diet. This scoping review aims to deepen the evidence on the relationship between OSCC and diet, following PRISMA-ScR guidelines, and was registered on Open Science Framework. Searches were performed in four electronic databases: MEDLINE, Embase, Web of Science, and Lilacs, without date or language restrictions. Studies were evaluated, extracted, and compiled in a narrative table. Seventeen studies with 10,954 patients were analyzed. Most patients were male (74.63%), aged 18–89 (average 50.62). Studies were mainly from high (82%) and medium (17%) Human Development Index (HDI) countries. Dietary surveys included a Food Frequency Questionnaire (FFQ) (58.8%), interviews/questionnaires (17.6%), and an FFQ with a photographic atlas (5.9%). Certain foods in excess like fruits, vegetables, and tea were inversely associated with OSCC, while salty meats, dairy, coffee, sausages, and fried and spicy foods were positively associated. Due to the heterogeneity of the tools used to obtain food frequency data, the results should be interpreted cautiously. New standardized studies and randomized trials are essential to advance understanding and control confounding factors in this field.